{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:58:06Z","timestamp":1793732286093,"version":"4.6.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003178","name":"Alberta Glycomics Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003178","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009056","name":"Canadian Glycomics Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gangliosides are glycosphingolipids highly enriched in the brain, with important roles in cell signaling, cell-to-cell communication, and immunomodulation. Genetic defects in the ganglioside biosynthetic pathway result in severe neurodegenerative diseases, while a partial decrease in the levels of specific gangliosides was reported in Parkinson\u2019s disease and Huntington\u2019s disease. In models of both diseases and other conditions, administration of GM1\u2014one of the most abundant gangliosides in the brain\u2014provides neuroprotection. Most studies have focused on the direct neuroprotective effects of gangliosides on neurons, but their role in other brain cells, in particular microglia, is not known. In this study we investigated the effects of exogenous ganglioside administration and modulation of endogenous ganglioside levels on the response of microglia to inflammatory stimuli, which often contributes to initiation or exacerbation of neurodegeneration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In vitro studies were performed using BV2 cells, mouse, rat, and human primary microglia cultures. Modulation of microglial ganglioside levels was achieved by administration of exogenous gangliosides, or by treatment with GENZ-123346 and L\u2013\n                      <jats:italic>t<\/jats:italic>\n                      -PDMP, an inhibitor and an\u00a0activator of glycolipid biosynthesis, respectively. Response of microglia to inflammatory stimuli (LPS, IL-1\u03b2, phagocytosis of latex beads) was measured by analysis of gene expression and\/or secretion of pro-inflammatory cytokines. The effects of GM1 administration on microglia activation were also assessed in vivo in C57Bl\/6 mice, following intraperitoneal injection of LPS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GM1 decreased inflammatory microglia responses in vitro and in vivo, even when administered after microglia activation. These anti-inflammatory effects depended on the presence of the sialic acid residue in the GM1 glycan headgroup and the presence of a lipid tail. Other gangliosides shared similar anti-inflammatory effects in in vitro models, including GD3, GD1a, GD1b, and GT1b. Conversely, GM3 and GQ1b displayed pro-inflammatory activity. The anti-inflammatory effects of GM1 and other gangliosides were partially reproduced by increasing endogenous ganglioside levels with L\u2013\n                      <jats:italic>t<\/jats:italic>\n                      -PDMP, whereas inhibition of glycolipid biosynthesis exacerbated microglial activation in response to LPS stimulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data suggest that gangliosides are important modulators of microglia inflammatory responses and reveal that administration of GM1 and other complex gangliosides exerts anti-inflammatory effects on microglia that could be exploited therapeutically.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-021-02374-x","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T11:02:38Z","timestamp":1641466958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Anti-inflammatory role of GM1 and other gangliosides on microglia"],"prefix":"10.1186","volume":"19","author":[{"given":"Danny","family":"Galleguillos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asifa","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamaldeep","family":"Dhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gour C.","family":"Daskhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward N.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb","family":"Dworsky-Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Churchward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3060-0723","authenticated-orcid":false,"given":"Simonetta","family":"Sipione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"8","key":"2374_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tcb.2016.02.006","volume":"26","author":"JL Frost","year":"2016","unstructured":"Frost JL, Schafer DP. Microglia: architects of the developing nervous system. Trends Cell Biol. 2016;26(8):587\u201397.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"2374_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"5726","key":"2374_CR3","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314\u20138.","journal-title":"Science"},{"issue":"5","key":"2374_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nn.3358","volume":"16","author":"M Ueno","year":"2013","unstructured":"Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013;16(5):543\u201351.","journal-title":"Nat Neurosci"},{"issue":"7","key":"2374_CR5","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","volume":"155","author":"CN Parkhurst","year":"2013","unstructured":"Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596\u2013609.","journal-title":"Cell"},{"issue":"10","key":"2374_CR6","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1523\/JNEUROSCI.3441-12.2013","volume":"33","author":"CL Cunningham","year":"2013","unstructured":"Cunningham CL, Martinez-Cerdeno V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33(10):4216\u201333.","journal-title":"J Neurosci"},{"key":"2374_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","volume":"27","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol. 2009;27:119\u201345.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2374_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):193\u2013201.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2374_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"6","key":"2374_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","volume":"36","author":"A Crotti","year":"2015","unstructured":"Crotti A, Glass CK. The choreography of neuroinflammation in Huntington\u2019s disease. Trends Immunol. 2015;36(6):364\u201373.","journal-title":"Trends Immunol"},{"issue":"8","key":"2374_CR11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med. 2008;205(8):1869\u201377.","journal-title":"J Exp Med"},{"issue":"4","key":"2374_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG. Glial reactions in Parkinson\u2019s disease. Mov Disord. 2008;23(4):474\u201383.","journal-title":"Mov Disord"},{"key":"2374_CR13","doi-asserted-by":"publisher","first-page":"952375","DOI":"10.1155\/2013\/952375","volume":"2013","author":"SV More","year":"2013","unstructured":"More SV, Kumar H, Kim IS, Song SY, Choi DK. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mediators Inflamm. 2013;2013:952375.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2374_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuron.2009.08.039","volume":"64","author":"KM Lucin","year":"2009","unstructured":"Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64(1):110\u201322.","journal-title":"Neuron"},{"issue":"7","key":"2374_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"issue":"6301","key":"2374_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777\u201383.","journal-title":"Science"},{"issue":"7","key":"2374_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2018.04.004","volume":"39","author":"JY Zhou","year":"2018","unstructured":"Zhou JY, Oswald DM, Oliva KD, Kreisman LSC, Cobb BA. The glycoscience of immunity. Trends Immunol. 2018;39(7):523\u201335.","journal-title":"Trends Immunol"},{"key":"2374_CR18","volume-title":"Essentials of glycobiology","author":"RL Schnaar","year":"2021","unstructured":"Schnaar RL, Kinoshita T, et al. Glycosphingolipids. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, et al., editors. Essentials of glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2021."},{"key":"2374_CR19","unstructured":"Copyright 2015\u20132017 by The Consortium of Glycobiology Editors, La Jolla, California. All rights reserved; 2015; p. 125\u201335."},{"key":"2374_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/acprof:oso\/9780198525387.001.0001","volume-title":"Neuroglycobiology","author":"M Fukuda","year":"2005","unstructured":"Fukuda M, Rutishauser U, Schnaar RL. Neuroglycobiology. New York: Oxford University Press; 2005. p. 229."},{"issue":"9","key":"2374_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","volume":"584","author":"E Posse de Chaves","year":"2010","unstructured":"Posse de Chaves E, Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010;584(9):1748\u201359.","journal-title":"FEBS Lett"},{"key":"2374_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"SMJ Sipione","year":"2020","unstructured":"Sipione SMJ, Galleguillos D, Steinberg N, Kadam V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci. 2020;14:1\u201324.","journal-title":"Front Neurosci"},{"issue":"9","key":"2374_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10719-014-9563-5","volume":"31","author":"ML Allende","year":"2014","unstructured":"Allende ML, Proia RL. Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glycoconj J. 2014;31(9):613\u201322.","journal-title":"Glycoconj J"},{"issue":"3","key":"2374_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0197-0186(92)90057-X","volume":"20","author":"I Kracun","year":"1992","unstructured":"Kracun I, Rosner H, Drnovsek V, Vukelic Z, Cosovic C, Trbojevic-Cepe M, et al. Gangliosides in the human brain development and aging. Neurochem Int. 1992;20(3):421\u201331.","journal-title":"Neurochem Int"},{"issue":"2","key":"2374_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brainres.2005.06.068","volume":"1054","author":"L Mo","year":"2005","unstructured":"Mo L, Ren Q, Duchemin AM, Neff NH, Hadjiconstantinou M. GM1 and ERK signaling in the aged brain. Brain Res. 2005;1054(2):125\u201334.","journal-title":"Brain Res"},{"issue":"1","key":"2374_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1471-4159.1990.tb13305.x","volume":"54","author":"P Palestini","year":"1990","unstructured":"Palestini P, Masserini M, Sonnino S, Giuliani A, Tettamanti G. Changes in the ceramide composition of rat forebrain gangliosides with age. J Neurochem. 1990;54(1):230\u20135.","journal-title":"J Neurochem"},{"issue":"3","key":"2374_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000213109","volume":"29","author":"K Segler-Stahl","year":"1983","unstructured":"Segler-Stahl K, Webster JC, Brunngraber EG. Changes in the concentration and composition of human brain gangliosides with aging. Gerontology. 1983;29(3):161\u20138.","journal-title":"Gerontology"},{"issue":"11","key":"2374_CR28","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","volume":"30","author":"V Maglione","year":"2010","unstructured":"Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E, et al. Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1. J Neurosci. 2010;30(11):4072\u201380.","journal-title":"J Neurosci"},{"issue":"3","key":"2374_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","volume":"27","author":"PA Desplats","year":"2007","unstructured":"Desplats PA, Denny CA, Kass KE, Gilmartin T, Head SR, Sutcliffe JG, et al. Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease. Neurobiol Dis. 2007;27(3):265\u201377.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"2374_CR30","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jnr.23090","volume":"90","author":"G Wu","year":"2012","unstructured":"Wu G, Lu ZH, Kulkarni N, Ledeen RW. Deficiency of ganglioside GM1 correlates with Parkinson\u2019s disease in mice and humans. J Neurosci Res. 2012;90(10):1997\u20132008.","journal-title":"J Neurosci Res"},{"issue":"6","key":"2374_CR31","doi-asserted-by":"publisher","first-page":"e0199189","DOI":"10.1371\/journal.pone.0199189","volume":"13","author":"JS Schneider","year":"2018","unstructured":"Schneider JS. Altered expression of genes involved in ganglioside biosynthesis in substantia Nigra neurons in Parkinson\u2019s disease. PLoS ONE. 2018;13(6):e0199189.","journal-title":"PLoS ONE"},{"issue":"10","key":"2374_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/archneur.1991.00530220048018","volume":"48","author":"K Blennow","year":"1991","unstructured":"Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, et al. Gangliosides in cerebrospinal fluid in \u2018probable Alzheimer\u2019s disease.\u2019 Arch Neurol. 1991;48(10):1032\u20135.","journal-title":"Arch Neurol"},{"issue":"4","key":"2374_CR33","first-page":"301","volume":"4","author":"K Blennow","year":"1992","unstructured":"Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Mansson JE, et al. Differences in cerebrospinal fluid gangliosides between \u201cprobable Alzheimer\u2019s disease\u201d and normal aging. Aging (Milano). 1992;4(4):301\u20136.","journal-title":"Aging (Milano)"},{"key":"2374_CR34","doi-asserted-by":"crossref","unstructured":"Alpaugh M GD, Forero J, Morales LC, Lackey S, Kar P, Di Pardo A, Holt A, Kerr B, Todd K, Baker GB, Fouad K, Sipione S. Therapeutic and disease-modifying effects of ganglioside GM1 in mouse models of Huntington\u2019s disease. Submitted2017.","DOI":"10.15252\/emmm.201707763"},{"key":"2374_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3389\/fneur.2019.00859","volume":"10","author":"PJ Magistretti","year":"2019","unstructured":"Magistretti PJ, Geisler FH, Schneider JS, Li PA, Fiumelli H, Sipione S. Gangliosides: treatment avenues in neurodegenerative disease. Front Neurol. 2019;10:859.","journal-title":"Front Neurol"},{"issue":"4","key":"2374_CR36","first-page":"255","volume":"12","author":"A Pope-Coleman","year":"1998","unstructured":"Pope-Coleman A, Schneider JS. Effects of chronic GM1 ganglioside treatment on cognitieve and motor deficits in a slowly progressing model of parkinsonism in non-human primates. Restor Neurol Neurosci. 1998;12(4):255\u201366.","journal-title":"Restor Neurol Neurosci"},{"key":"2374_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1749-6632.1998.tb09688.x","volume":"845","author":"JS Schneider","year":"1998","unstructured":"Schneider JS. GM1 ganglioside in the treatment of Parkinson\u2019s disease. Ann N Y Acad Sci. 1998;845:363\u201373.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2374_CR38","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1038\/s41598-019-42847-x","volume":"9","author":"JS Schneider","year":"2019","unstructured":"Schneider JS, Aras R, Williams CK, Koprich JB, Brotchie JM, Singh V. GM1 ganglioside modifies alpha-synuclein toxicity and is neuroprotective in a rat alpha-synuclein model of Parkinson\u2019s disease. Sci Rep. 2019;9(1):8362.","journal-title":"Sci Rep"},{"issue":"11","key":"2374_CR39","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.15252\/emmm.201707763","volume":"9","author":"M Alpaugh","year":"2017","unstructured":"Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, et al. Disease-modifying effects of ganglioside GM1 in Huntington\u2019s disease models. EMBO Mol Med. 2017;9(11):1537\u201357.","journal-title":"EMBO Mol Med"},{"issue":"9","key":"2374_CR40","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1073\/pnas.1114502109","volume":"109","author":"A Di Pardo","year":"2012","unstructured":"Di Pardo A, Maglione V, Alpaugh M, Horkey M, Atwal RS, Sassone J, et al. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci U S A. 2012;109(9):3528\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2374_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1471-4159.2010.07067.x","volume":"116","author":"Y Ohmi","year":"2011","unstructured":"Ohmi Y, Tajima O, Ohkawa Y, Yamauchi Y, Sugiura Y, Furukawa K, et al. Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J Neurochem. 2011;116(5):926\u201335.","journal-title":"J Neurochem"},{"key":"2374_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1742-2094-11-61","volume":"11","author":"Y Ohmi","year":"2014","unstructured":"Ohmi Y, Ohkawa Y, Tajima O, Sugiura Y, Furukawa K, Furukawa K. Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord. J Neuroinflammation. 2014;11:61.","journal-title":"J Neuroinflammation"},{"key":"2374_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2018.02.001","volume":"95","author":"G Gong","year":"2018","unstructured":"Gong G, Yin L, Yuan L, Sui D, Sun Y, Fu H, et al. Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K\/AKT-Nrf2 pathway. Mol Immunol. 2018;95:91\u20138.","journal-title":"Mol Immunol"},{"issue":"3","key":"2374_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/glia.10274","volume":"44","author":"J Saura","year":"2003","unstructured":"Saura J, Tusell JM, Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia. 2003;44(3):183\u20139.","journal-title":"Glia"},{"key":"2374_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1742-4690-11-35","volume":"11","author":"JG Walsh","year":"2014","unstructured":"Walsh JG, Reinke SN, Mamik MK, McKenzie BA, Maingat F, Branton WG, et al. Rapid inflammasome activation in microglia contributes to brain disease in HIV\/AIDS. Retrovirology. 2014;11:35.","journal-title":"Retrovirology"},{"issue":"2\u20133","key":"2374_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-5728(90)90073-V","volume":"27","author":"E Blasi","year":"1990","unstructured":"Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf\/v-myc carrying retrovirus. J Neuroimmunol. 1990;27(2\u20133):229\u201337.","journal-title":"J Neuroimmunol"},{"key":"2374_CR47","doi-asserted-by":"crossref","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.","DOI":"10.1186\/gb-2002-3-7-research0034"},{"issue":"2","key":"2374_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14573\/altex.2009.2.83","volume":"26","author":"A Henn","year":"2009","unstructured":"Henn A, Lund S, Hedtj\u00e4rn M, Schrattenholz A, P\u00f6rzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex. 2009;26(2):83\u201394.","journal-title":"Altex"},{"key":"2374_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbi.2017.10.025","volume":"72","author":"TC Franklin","year":"2018","unstructured":"Franklin TC, Xu C, Duman RS. Depression and sterile inflammation: essential role of danger associated molecular patterns. Brain Behav Immun. 2018;72:2\u201313.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"2374_CR50","doi-asserted-by":"publisher","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","volume":"290","author":"JS Park","year":"2006","unstructured":"Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006;290(3):C917\u201324.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2374_CR51","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fimmu.2019.01000","volume":"10","author":"S Azam","year":"2019","unstructured":"Azam S, Jakaria M, Kim IS, Kim J, Haque ME, Choi DK. Regulation of toll-like receptor (TLR) signaling pathway by polyphenols in the treatment of age-linked neurodegenerative diseases: focus on TLR4 signaling. Front Immunol. 2019;10:1000.","journal-title":"Front Immunol"},{"issue":"2","key":"2374_CR52","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1432-1033.1979.tb13144.x","volume":"97","author":"H Rauvala","year":"1979","unstructured":"Rauvala H. Monomer-micelle transition of the ganglioside GM1 and the hydrolysis by clostridium perfringens neuraminidase. Eur J Biochem. 1979;97(2):555\u201364.","journal-title":"Eur J Biochem"},{"issue":"12","key":"2374_CR53","doi-asserted-by":"publisher","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","volume":"113","author":"ML Bennett","year":"2016","unstructured":"Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016;113(12):E1738\u201346.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2374_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/2347-8659.139719","volume":"1","author":"IB Hovens","year":"2014","unstructured":"Hovens IB, Nyakas C, Schoemaker RG. A novel method for evaluating microglial activation using ionized calcium-binding adaptor protein-1 staining: cell body to cell size ratio. Neuroimmunol Neuroinflammation. 2014;1:82\u20138.","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"2374_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnana.2019.00103","volume":"13","author":"N Garc\u00eda-Magro","year":"2019","unstructured":"Garc\u00eda-Magro N, Martin YB, Palomino-Antolin A, Egea J, Negredo P, Avenda\u00f1o C. Multiple morphometric assessment of microglial cells in deafferented spinal trigeminal nucleus. Front Neuroanat. 2019;13:103.","journal-title":"Front Neuroanat"},{"issue":"2","key":"2374_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12035-009-8077-9","volume":"40","author":"MA Lynch","year":"2009","unstructured":"Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol. 2009;40(2):139\u201356.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"2374_CR57","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/jnr.23883","volume":"95","author":"AMW Taylor","year":"2017","unstructured":"Taylor AMW, Mehrabani S, Liu S, Taylor AJ, Cahill CM. Topography of microglial activation in sensory- and affect-related brain regions in chronic pain. J Neurosci Res. 2017;95(6):1330\u20135.","journal-title":"J Neurosci Res"},{"issue":"6","key":"2374_CR58","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334.","journal-title":"Cell"},{"key":"2374_CR59","doi-asserted-by":"crossref","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. 2019;11(6).","DOI":"10.15252\/emmm.201810248"},{"issue":"7","key":"2374_CR60","doi-asserted-by":"publisher","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajamaki","year":"2010","unstructured":"Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, Kovanen PT, et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE. 2010;5(7):e11765.","journal-title":"PLoS ONE"},{"issue":"2","key":"2374_CR61","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1073\/pnas.0709191105","volume":"105","author":"N Kudo","year":"2008","unstructured":"Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, et al. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A. 2008;105(2):488\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2374_CR62","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"J Fantini","year":"2009","unstructured":"Fantini J, Barrantes FJ. Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta. 2009;1788(11):2345\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2374_CR63","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/oxfordjournals.jbchem.a124774","volume":"117","author":"J Inokuchi","year":"1995","unstructured":"Inokuchi J, Usuki S, Jimbo M. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells. J Biochem. 1995;117(4):766\u201373.","journal-title":"J Biochem"},{"issue":"11","key":"2374_CR64","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ng1460","volume":"36","author":"MA Simpson","year":"2004","unstructured":"Simpson MA, Cross H, Proukakis C, Priestman DA, Neville DC, Reinkensmeier G, et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet. 2004;36(11):1225\u20139.","journal-title":"Nat Genet"},{"issue":"5","key":"2374_CR65","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ejhg.2012.202","volume":"21","author":"K Fragaki","year":"2013","unstructured":"Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, et al. Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet. 2013;21(5):528\u201334.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"2374_CR66","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/hmg\/ddt434","volume":"23","author":"L Boccuto","year":"2014","unstructured":"Boccuto L, Aoki K, Flanagan-Steet H, Chen CF, Fan X, Bartel F, et al. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet. 2014;23(2):418\u201333.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2374_CR67","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/cge.12312","volume":"86","author":"SM Wakil","year":"2014","unstructured":"Wakil SM, Monies DM, Ramzan K, Hagos S, Bastaki L, Meyer BF, et al. Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia. Clin Genet. 2014;86(5):500\u20131.","journal-title":"Clin Genet"},{"issue":"Pt 12","key":"2374_CR68","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/brain\/awt270","volume":"136","author":"GV Harlalka","year":"2013","unstructured":"Harlalka GV, Lehman A, Chioza B, Baple EL, Maroofian R, Cross H, et al. Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain. 2013;136(Pt 12):3618\u201324.","journal-title":"Brain"},{"issue":"1","key":"2374_CR69","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","volume":"93","author":"A Boukhris","year":"2013","unstructured":"Boukhris A, Schule R, Loureiro JL, Lourenco CM, Mundwiller E, Gonzalez MA, et al. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet. 2013;93(1):118\u201323.","journal-title":"Am J Hum Genet"},{"key":"2374_CR70","first-page":"46","volume":"124","author":"JA Shayman","year":"2013","unstructured":"Shayman JA. The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity? Trans Am Clin Climatol Assoc. 2013;124:46\u201360.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"5","key":"2374_CR71","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/01.STR.21.5.825","volume":"21","author":"S Oppenheimer","year":"1990","unstructured":"Oppenheimer S. GM1 ganglioside therapy in acute ischemic stroke. Stroke. 1990;21(5):825.","journal-title":"Stroke"},{"issue":"1","key":"2374_CR72","first-page":"24","volume":"265","author":"RP Simon","year":"1993","unstructured":"Simon RP, Chen J, Graham SH. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study. J Pharmacol Exp Ther. 1993;265(1):24\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2374_CR73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<120::AID-SYN5>3.0.CO;2-Y","volume":"36","author":"A Pope-Coleman","year":"2000","unstructured":"Pope-Coleman A, Tinker JP, Schneider JS. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys. Synapse. 2000;36(2):120\u20138.","journal-title":"Synapse"},{"issue":"1\u20132","key":"2374_CR74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","volume":"324","author":"JS Schneider","year":"2013","unstructured":"Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du W. A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson\u2019s disease patients. J Neurol Sci. 2013;324(1\u20132):140\u20138.","journal-title":"J Neurol Sci"},{"key":"2374_CR75","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/bs.pmbts.2017.12.009","volume":"156","author":"RW Ledeen","year":"2018","unstructured":"Ledeen RW, Wu G. Gangliosides, alpha-Synuclein, and Parkinson\u2019s disease. Prog Mol Biol Transl Sci. 2018;156:435\u201354.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"7","key":"2374_CR76","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tibs.2015.04.005","volume":"40","author":"RW Ledeen","year":"2015","unstructured":"Ledeen RW, Wu G. The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci. 2015;40(7):407\u201318.","journal-title":"Trends Biochem Sci"},{"issue":"19\u201320","key":"2374_CR77","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00018-005-5188-y","volume":"62","author":"I Mocchetti","year":"2005","unstructured":"Mocchetti I. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci. 2005;62(19\u201320):2283\u201394.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"2374_CR78","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1172\/JCI64484","volume":"122","author":"W Kwan","year":"2012","unstructured":"Kwan W, Trager U, Davalos D, Chou A, Bouchard J, Andre R, et al. Mutant huntingtin impairs immune cell migration in Huntington disease. J Clin Invest. 2012;122(12):4737\u201347.","journal-title":"J Clin Invest"},{"issue":"4","key":"2374_CR79","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17(4):513\u201321.","journal-title":"Nat Neurosci"},{"issue":"8","key":"2374_CR80","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","volume":"117","author":"T Moller","year":"2010","unstructured":"Moller T. Neuroinflammation in Huntington\u2019s disease. J Neural Transm. 2010;117(8):1001\u20138.","journal-title":"J Neural Transm"},{"key":"2374_CR81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2008.09.072","volume":"1244","author":"JY Park","year":"2008","unstructured":"Park JY, Kim HY, Jou I, Park SM. GM1 induces p38 and microtubule dependent ramification of rat primary microglia in vitro. Brain Res. 2008;1244:13\u201323.","journal-title":"Brain Res"},{"issue":"3","key":"2374_CR82","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/glia.20069","volume":"48","author":"KJ Min","year":"2004","unstructured":"Min KJ, Pyo HK, Yang MS, Ji KA, Jou I, Joe EH. Gangliosides activate microglia via protein kinase C and NADPH oxidase. Glia. 2004;48(3):197\u2013206.","journal-title":"Glia"},{"issue":"5","key":"2374_CR83","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/emm.2004.58","volume":"36","author":"KJ Min","year":"2004","unstructured":"Min KJ, Yang MS, Jou I, Joe EH. Protein kinase A mediates microglial activation induced by plasminogen and gangliosides. Exp Mol Med. 2004;36(5):461\u20137.","journal-title":"Exp Mol Med"},{"issue":"49","key":"2374_CR84","doi-asserted-by":"publisher","first-page":"34584","DOI":"10.1074\/jbc.274.49.34584","volume":"274","author":"H Pyo","year":"1999","unstructured":"Pyo H, Joe E, Jung S, Lee SH, Jou I. Gangliosides activate cultured rat brain microglia. J Biol Chem. 1999;274(49):34584\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"2374_CR85","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4049\/jimmunol.148.6.1753","volume":"148","author":"HW Ziegler-Heitbrock","year":"1992","unstructured":"Ziegler-Heitbrock HW, Kafferlein E, Haas JG, Meyer N, Strobel M, Weber C, et al. Gangliosides suppress tumor necrosis factor production in human monocytes. J Immunol. 1992;148(6):1753\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"2374_CR86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.intimp.2015.05.044","volume":"28","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cui Y, Cao F, Qin Y, Li W, Zhang J. Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-kappaB signaling pathways through TLR4. Int Immunopharmacol. 2015;28(1):136\u201345.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2374_CR87","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.4049\/jimmunol.180.7.4425","volume":"180","author":"W Shen","year":"2008","unstructured":"Shen W, Stone K, Jales A, Leitenberg D, Ladisch S. Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides. J Immunol. 2008;180(7):4425\u201332.","journal-title":"J Immunol"},{"issue":"2","key":"2374_CR88","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/A:1022557920150","volume":"24","author":"T Ariga","year":"1999","unstructured":"Ariga T, Yu RK. GM1 inhibits amyloid beta-protein-induced cytokine release. Neurochem Res. 1999;24(2):219\u201326.","journal-title":"Neurochem Res"},{"issue":"3","key":"2374_CR89","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1385\/JMN:17:3:371","volume":"17","author":"T Ariga","year":"2001","unstructured":"Ariga T, Kiso M, Hasegawa A, Miyatake T. Gangliosides inhibit the release of interleukin-1beta in amyloid beta-protein-treated human monocytic cells. J Mol Neurosci. 2001;17(3):371\u20137.","journal-title":"J Mol Neurosci"},{"issue":"5","key":"2374_CR90","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong J-S, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453\u201362.","journal-title":"Glia"},{"issue":"22","key":"2374_CR91","doi-asserted-by":"publisher","first-page":"20026","DOI":"10.1074\/jbc.M109218200","volume":"277","author":"H Kanazawa","year":"2002","unstructured":"Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y. Macrophage\/microglia-specific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma -dependent pathway. J Biol Chem. 2002;277(22):20026\u201332.","journal-title":"J Biol Chem"},{"issue":"Pt 17","key":"2374_CR92","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1242\/jcs.113.17.3073","volume":"113","author":"K Ohsawa","year":"2000","unstructured":"Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages\/microglia. J Cell Sci. 2000;113(Pt 17):3073\u201384.","journal-title":"J Cell Sci"},{"issue":"2","key":"2374_CR93","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994;180(2):147\u201350.","journal-title":"Neurosci Lett"},{"key":"2374_CR94","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1749-6632.1996.tb34420.x","volume":"777","author":"M Hull","year":"1996","unstructured":"Hull M, Berger M, Volk B, Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer\u2019s disease patients may precede transformation of diffuse into neuritic plaques. Ann N Y Acad Sci. 1996;777:205\u201312.","journal-title":"Ann N Y Acad Sci"},{"issue":"6 Pt A","key":"2374_CR95","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","volume":"1863","author":"M Rothaug","year":"2016","unstructured":"Rothaug M, Becker-Pauly C, Rose-John S. The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta. 2016;1863(6 Pt A):1218\u201327.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2374_CR96","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1084\/jem.183.6.2417","volume":"183","author":"JA Wagner","year":"1996","unstructured":"Wagner JA. Is IL-6 both a cytokine and a neurotrophic factor? J Exp Med. 1996;183(6):2417\u20139.","journal-title":"J Exp Med"},{"issue":"1","key":"2374_CR97","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/exnr.1995.1082","volume":"136","author":"Y Akaneya","year":"1995","unstructured":"Akaneya Y, Takahashi M, Hatanaka H. Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol. 1995;136(1):44\u201352.","journal-title":"Exp Neurol"},{"issue":"6","key":"2374_CR98","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1084\/jem.183.6.2627","volume":"183","author":"H Hirota","year":"1996","unstructured":"Hirota H, Kiyama H, Kishimoto T, Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med. 1996;183(6):2627\u201334.","journal-title":"J Exp Med"},{"issue":"5337","key":"2374_CR99","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.278.5337.477","volume":"278","author":"A Bonni","year":"1997","unstructured":"Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 1997;278(5337):477\u201383.","journal-title":"Science"},{"issue":"9","key":"2374_CR100","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/glia.22689","volume":"62","author":"AJ Chucair-Elliott","year":"2014","unstructured":"Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ. Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia. 2014;62(9):1418\u201334.","journal-title":"Glia"},{"issue":"2","key":"2374_CR101","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0008-8749(87)90173-0","volume":"106","author":"JM Cavaillon","year":"1987","unstructured":"Cavaillon JM, Fitting C, Hauttecoeur B, Haeffner-Cavaillon N. Inhibition by gangliosides of the specific binding of lipopolysaccharide (LPS) to human monocytes prevents LPS-induced interleukin-1 production. Cell Immunol. 1987;106(2):293\u2013303.","journal-title":"Cell Immunol"},{"issue":"4","key":"2374_CR102","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0165-2478(88)90164-2","volume":"19","author":"KC Jeng","year":"1988","unstructured":"Jeng KC, Chen TL, Lan JL. Gangliosides suppression of murine lymphoproliferation and interleukin 1 production. Immunol Lett. 1988;19(4):335\u201340.","journal-title":"Immunol Lett"},{"issue":"5","key":"2374_CR103","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2353\/ajpath.2006.050924","volume":"168","author":"I Jou","year":"2006","unstructured":"Jou I, Lee JH, Park SY, Yoon HJ, Joe EH, Park EJ. Gangliosides trigger inflammatory responses via TLR4 in brain glia. Am J Pathol. 2006;168(5):1619\u201330.","journal-title":"Am J Pathol"},{"issue":"12","key":"2374_CR104","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.4049\/jimmunol.0902780","volume":"183","author":"CR Boyd","year":"2009","unstructured":"Boyd CR, Orr SJ, Spence S, Burrows JF, Elliott J, Carroll HP, et al. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol. 2009;183(12):7703\u20139.","journal-title":"J Immunol"},{"issue":"10","key":"2374_CR105","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley MS, Crocker PR, Paulson JC. Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol. 2014;14(10):653\u201366.","journal-title":"Nat Rev Immunol"},{"key":"2374_CR106","doi-asserted-by":"crossref","unstructured":"Chen G-Y, Brown NK, Wu W, Khedri Z, Yu H, Chen X, et al. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. eLife. 2014;3.","DOI":"10.7554\/eLife.04066"},{"issue":"6","key":"2374_CR107","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/jnc.14146","volume":"143","author":"E Chiricozzi","year":"2017","unstructured":"Chiricozzi E, Pom\u00e8 DY, Maggioni M, Di Biase E, Parravicini C, Palazzolo L, et al. Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells. J Neurochem. 2017;143(6):645\u201359.","journal-title":"J Neurochem"},{"issue":"1","key":"2374_CR108","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino S, Mauri L, Chigorno V, Prinetti A. Gangliosides as components of lipid membrane domains. Glycobiology. 2007;17(1):1R-13R.","journal-title":"Glycobiology"},{"issue":"8","key":"2374_CR109","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1128\/IAI.67.8.3824-3829.1999","volume":"67","author":"T van der Bruggen","year":"1999","unstructured":"van der Bruggen T, Nijenhuis S, van Raaij E, Verhoef J, van Asbeck BS. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1\/MEK1-MEK2\/ERK1-ERK2 pathway. Infect Immun. 1999;67(8):3824\u20139.","journal-title":"Infect Immun"},{"issue":"10","key":"2374_CR110","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.4049\/jimmunol.0902456","volume":"184","author":"P Gais","year":"2010","unstructured":"Gais P, Tiedje C, Altmayr F, Gaestel M, Weighardt H, Holzmann B. TRIF signaling stimulates translation of TNF-\u03b1 mRNA via prolonged activation of MK2. J Immunol. 2010;184(10):5842\u20138.","journal-title":"J Immunol"},{"issue":"7","key":"2374_CR111","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.4049\/jimmunol.0903778","volume":"184","author":"B Mazumder","year":"2010","unstructured":"Mazumder B, Li X, Barik S. Translation control: a multifaceted regulator of inflammatory response. J Immunol. 2010;184(7):3311\u20139.","journal-title":"J Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02374-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T23:34:21Z","timestamp":1674344061000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2374"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02374-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human primary microglia cultures were prepared from fetal tissue obtained from electively terminated healthy pregnancies with written informed consent of the donors (Pro000027660), as approved by the University of Alberta Human Research Ethics Board (Biomedical). All procedures on animals were approved by the University of Alberta Animal Care and Use Committee (AUP00000336) and were in accordance with the guidelines of the Canadian Council on Animal Care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SS and the University of Alberta hold a patent for the use of GM1 in HD. There are no other competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}